J&J/McNeil Consent Decree Prequel Tops OTC Stories, Switch Leads Topics In 2014

“The Tan Sheet” readers also made top stories of FDA’s rejection of Bayer’s petition for aspirin as primary prevention of heart attack stroke; advisors recommending FDA consider additional label warnings for OTC NSAIDS; and FDA seeking to overhaul its OTC drug monograph process to be “more agile and responsive.”

Rx-to-OTC switch news could be a full meal for readers of “The Tan Sheet,” but those articles amount to appetizers for a plate of Johnson & Johnson OTC manufacturing history.

From the “The Tan Sheet” 2014 menu, readers selected more articles about OTC switches than any other topic. The news included new drug applications, such as Merck & Co. Inc

More from United States

More from North America